Enterol

Medicinal product

(Invented) name

Enterol

Active substance (s)

Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės

Strength

250 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A07FA02, Saccharomyces boulardii

Marketing authorisation holder

Biocodex, Prancūzija

Date of authorisation

2004-04-27

Date of renewal

2013-02-13

Documents

0011 Enterol milt geriam tirp_kaps RPP 2024 07 01.docx

0011 Pakuotės lapelis 2024 07 01.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Liofilizuotos Saccharomyces boulardii CNCM I-745 ląstelės	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
11642	16092	1016092	buteliukas	N10		Nereceptinis	LT/1/04/0011/002	Tiekiama	-	-	No	-	-	Download
29250	31751	1031751	buteliukas	N20		Nereceptinis	LT/1/04/0011/004	Tiekiama	-	-	No	-	-	Download
100968	87079	1087079	buteliukas	N30		Nereceptinis	LT/1/04/0011/005	Tiekiama	-	-	No	-	-
100969	87080	1087080	buteliukas	N50		Nereceptinis	LT/1/04/0011/006	Netiekiama	-	-	No	-	-
101757	87862	1087862	lizdinė plokštelė	N30		Nereceptinis	LT/1/04/0011/007	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2013-02-13	Perregistruotas
2004-04-27	Registruotas